Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-22-023021

Director acquired 379 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Dubin Glenn Director 2022-04-04 Grant or award +379 $26.46 $10,028 873 D
Loading xslF345X03/doc4.xml…